EDAP TMS Past Earnings Performance

Past criteria checks 0/6

EDAP TMS's earnings have been declining at an average annual rate of -68.3%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 9.4% per year.

Key information

-68.3%

Earnings growth rate

-66.3%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate9.4%
Return on equity-51.9%
Net Margin-34.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How EDAP TMS makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:EDA Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2463-22358
30 Jun 2462-20348
31 Mar 2461-18328
31 Dec 2360-21347
30 Sep 2357-21356
30 Jun 2357-17336
31 Mar 2357-11305
31 Dec 2255-3245
30 Sep 22534214
30 Jun 22513204
31 Mar 22470184
31 Dec 21441173
30 Sep 21450154
30 Jun 21450144
31 Mar 21440134
31 Dec 2042-2144
30 Sep 2038-3144
30 Jun 2039-2144
31 Mar 20420154
31 Dec 19452154
30 Sep 19464154
30 Jun 19442154
31 Mar 19400144
31 Dec 18390144
30 Sep 1836-1134
30 Jun 1835-1134
31 Mar 1836-2134
31 Dec 1736-1134
30 Sep 1736-2134
30 Jun 17370134
31 Mar 17364124
31 Dec 16364124
30 Sep 163710123
30 Jun 16354113
31 Mar 16352113
31 Dec 1532-2113
30 Sep 1527-9103
30 Jun 15272103
31 Mar 1525-4103
31 Dec 1426-1103
30 Sep 14282103
30 Jun 1427-593
31 Mar 1426092
31 Dec 1324-593

Quality Earnings: EDA is currently unprofitable.

Growing Profit Margin: EDA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EDA is unprofitable, and losses have increased over the past 5 years at a rate of 68.3% per year.

Accelerating Growth: Unable to compare EDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EDA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: EDA has a negative Return on Equity (-51.87%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:21
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EDAP TMS S.A. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew D'SilvaB. Riley Securities, Inc.
null nullCG Capital
Swayampakula RamakanthH.C. Wainwright & Co.